<DOC>
	<DOCNO>NCT01396681</DOCNO>
	<brief_summary>This phase â…¡ Trial Postoperative Adjuvant Gemcitabine Cisplatin Chemotherapy Followed Chemoradiation With Gemcitabine Patients With Resected Pancreatic Cancer .</brief_summary>
	<brief_title>Adjuvant Gemcitabine Cisplatin Followed Chemoradiation Resected Pancreatic Cancer</brief_title>
	<detailed_description>The primary study objective evaluate recurrence/metastasis free survival 12 month postoperative adjuvant treatment incorporate gemcitabine plus cisplatin chemotherapy follow chemoradiation gemcitabine follow maintenance chemotherapy gemcitabine .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>1 . Give write informed consent prior study specific screening procedure , understand patient right withdraw study time , without prejudice . 2 . Be 18 75 year age . 3 . Patients ambulatory ECOG Performance Status 02 . 4 . Histologically confirm pancreatic adenocarcinoma . 5 . Received curative resection ( R0 resection ) stage 1b ~ 2b pancreatic cancer ( accord AJCC staging , 6th edition Appendix 1 ) , 8 week elapse since time operation . 6 . WBC least 3,000/mm3 OR Absolute neutrophil count least 1,500/mm3 . Platelet count least 100,000/mm3 . 7 . Bilirubin le 2.0 mg/dL , AST le 3 time upper limit normal ( ULN ) . Serum creatinine great 1.5 time ULN . 1 . Pregnant lactate woman . 2 . Woman childbearing potential either positive pregnancy test baseline . 3 . Woman childbearing potential use reliable appropriate contraceptive method ( postmenopausal woman must amenorrheic least 12 month consider nonchildbearing potential ) . 4 . Sexually active male unwilling practice contraception study . 5 . Prior chemotherapy treatment pancreatic carcinoma . 6 . Radiotherapy incorporate radiation field 25 % active bone marrow . 7 . History another malignancy within last five year except cure basal cell carcinoma skin cure carcinoma insitu uterine cervix . 8 . Clinically significant cardiac disease ( e.g . congestive heart failure , symptomatic coronary artery disease , cardiac arrhythmia well controlled medication ) . 9 . Participation investigational drug study within four week precede start study treatment . 10 . Serious , uncontrolled , intercurrent infection ( ) . 11 . Other significant medical condition would , judgment investigator , make administration study drug unsafe .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>resect pancreatic cancer</keyword>
</DOC>